Entry Inhibitors - The Body

Now Live: Breaking Research From AIDS 2008: Podcasts, Interviews, Videos & More >>

BROWSE TOPICS IN HIV TREATMENT:

HIV Treatment: Home Page

Just Diagnosed

HIV Medications

First Steps to Treatment

HIV Drug Resistance

Switching or Stopping Treatment

Third Line/Rescue Treatment

Hepatitis C Coinfection

Women & Pregnancy

HIV Treatment for Children

Side Effects & Health Problems

Research & Experimental Drugs

HIV Treatment in the Developing World

Entry Inhibitors

Overview | Fuzeon (Enfuvirtide, T-20) | Selzentry (Maraviroc, Celsentri) | Entry Inhibitors in Development

Overview/General Research

Characteristics of Fusion and Integrase Inhibitors, and CCR5 Antagonists (PDF) (January 29, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents. For the full guidelines, click here (PDF).
From AIDSinfo
Fuzeon -- A Review of the First Entry Inhibitor (October 2003)
A look at how entry inhibitors and Fuzeon work.
To read PDF, click here
From The Body
New Anti-HIV Therapies: Entry Inhibitors (January 2003)
From Project Inform
Entry Inhibitors: The Bouncers at the Door (Winter 2002/2003)
To read PDF, click here
In ACRIA Update, from AIDS Community Research Initiative of America
New Drugs: Attacking Chemokine Receptors (March 2002)
In Hopkins HIV Report
New Targets Bring New Challenges (March 2002)
A closer look at integrase and entry inhibitors.
In GMHC Treatment Issues, from Gay Men's Health Crisis

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.